# EDGAR Filing Document

**Accession Number:** 0000931491
**File Stem:** 0001413042-23-000071
**Filing Date:** 2023-1
**Character Count:** 105247
**Document Hash:** abb5e9013206aaaa797b4a69419e92a5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001413042-23-000071.hdr.sgml**: 20230130

**ACCESSION NUMBER**: 0001413042-23-000071

**CONFORMED SUBMISSION TYPE**: N-CSR

**PUBLIC DOCUMENT COUNT**: 9

**CONFORMED PERIOD OF REPORT**: 20221130

**FILED AS OF DATE**: 20230130

**DATE AS OF CHANGE**: 20230130

**EFFECTIVENESS DATE**: 20230130

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CAPITAL MANAGEMENT INVESTMENT TRUST
- **CENTRAL INDEX KEY:** 0000931491
- **IRS NUMBER:** 566459396
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1130

**FILING VALUES:**
- **FORM TYPE:** N-CSR
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-08822
- **FILM NUMBER:** 23569240

**BUSINESS ADDRESS:**
- **STREET 1:** 140 BROADWAY
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10005
- **BUSINESS PHONE:** 888-626-3863

**MAIL ADDRESS:**
- **STREET 1:** 140 BROADWAY
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10005

## Series and Classes Contracts Data

### Wellington Shields All-Cap Fund (Series ID: S000010456)

| Class ID   | Class Name           | Ticker Symbol   |
|:---|:---|:---|
| C000028882 | Institutional Shares | WSACX           |

UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION <br> WASHINGTON, D.C. 20549

**FORM N-CSR**

**CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT <br> INVESTMENT COMPANIES**

Investment Company Act file number <u>811-08822</u>

**CAPITAL MANAGEMENT INVESTMENT TRUST**<br> (Exact name of registrant as specified in charter)

**<u>140 Broadway, New York, New York, 10005</u>**<br> (Address of principal executive offices) (Zip code)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**CT Corporation System <br> 115 Federal Street <br> <u>Suite 700, Boston, MA 02110</u>**<br> (Name and address of agent for service)

**Registrant's telephone number, including area code: <u>(888) 626 3863</u>**

**Date of fiscal year end: <u>November 30</u>**

**Date of reporting period: <u>November 30, 2022</u>**

**Item 1. Report to Stockholders.**

------

Wellington Shields All-Cap Fund

Institutional Shares (WSACX)

For Investors Seeking Capital Appreciation

**ANNUAL REPORT**

**<u>November 30, 2022</u>**

------

**Wellington Shields All-Cap Fund**<br> **Annual Report**<br> **November 30, 2022**<br> **(UNAUDITED)**

The Wellington Shields All-Cap Fund Institutional Shares (the "All-Cap Fund") had a total return of negative 15.25% for the fiscal year ending November 30, 2022, compared with returns of negative 10.66% for the Russell 1000® Index\*, negative 9.21% for the S&P 500® Total Return Index\* ("S&P 500") and 1.67% for the Dow Jones Industrial Average Index\* for the same period. The All-Cap Fund performance was negatively impacted by declines in GXO Logistics Inc., Amazon Inc., and Tesla Inc while Constellation Energy Corp., Diamondback Energy Inc, and McKesson Corp. were positive contributors to the portfolio performance.

Two seminal events defined the 2022 investment landscape: the Federal Reserve pivoted from providing liquidity to removing liquidity and Russia's invasion of Ukraine disrupted global food and energy supplies, exacerbating inflation already stoked by years of monetary and fiscal largesse.

The fiscal year started with inflation at a hot 6.2% up sharply from year-ago levels of 1.2% . In December, the Federal Reserve announced their intentions to arrest inflation by raising interest rates and reducing its balance sheet. The Federal Reserve balance sheet peaked over $8.9 trillion in mid-April before declining by $381 billion through the end of November. During the year, six interest rate hikes increased the Fed Funds rate off the zero bound to 4.25% .

The withdrawal of liquidity and increased rates were especially painful for high multiple companies. As a result, market leadership shifted with the formerly leading mega cap growth companies under-performing while the energy sector, benefitted from a war induced spike in the price of oil, and a new focus on capital discipline by U.S. producers outperformed for the duration of the year.

Inflation likely peaked for this cycle at 9.1% in June, retreating to 7.1% by the end of November. However, this is still well above the -0.1% to 3.9% range that defined the prior decade. More importantly, it is above the Fed's desired 2% level, implying tighter monetary policy ahead. While inflation is beneficial to revenues as prices increase, it results in decreased unit volume as higher priced food, rent, and energy crowd out other consumer purchases.

Inflation also squeezes corporate margins, often resulting in forced cost reductions taking the form of layoffs or reduced capital expenditures. Layoffs are essential to cooling labor demand, which prevents a wage spiral that could entrench inflation. With the Fed adamant about preventing that outcome, the net result may likely be recession, lower earnings in 2023, or both - an outlook corroborated by the currently inverted yield curve.

Equity investors may look to idiosyncratic themes to find companies that can grow through this challenging environment. Two government policies, the Infrastructure Investment & Jobs Act (November 2021) and the Inflation Reduction Act (August 2022), provided funding and incentives for investment in roads & civil infrastructure, hydrogen, solar and nuclear energy. The war in Ukraine is forcing Europe to remove its energy dependence from Russia and invest in defense. The widening rift between China and the West is driving companies to "on-shore" or "near shore" supply chains, driving investment in new manufacturing capacity especially in technology and semiconductors.

These areas provide investment opportunities. Companies that produce necessities such as consumer staples and provide healthcare are also at a relative advantage in this environment.

Sincerely, ![](wellingtonn-csr11302022x3x1.jpg) ![](wellingtonn-csr11302022x3x2.jpg)

W. Jameson McFadden <br> President<br> Capital Management Associates, Inc. Alexander L.M. Cripps, CFA <br> Portfolio Manager<br> Capital Management Associates, Inc.

**2022 Annual Report 1**

------

*\* The Russell 1000® Index is an index of approximately 1,000 of the largest companies in the U.S. equity market. The Russell 1000® Index is a subset of the Russell 3000® Index. It represents the top companies by market capitalization. The S&P 500® Total Return Index by Standard & Poor's Corp. is a capitalization-weighted index comprising 500 issues listed on various exchanges, representing the performance of the stock market generally. The Dow Jones Industrial Average Index, compiled by Dow Jones, gauges the performance of the industrial component of U.S. stock markets. Please note that indices do not take into account any fees and expenses of investing in the individual securities that they track and individuals cannot invest directly in any index. The Fund may or may not purchase the types of securities represented by the S&P 500® Total Return Index, Russell 1000® Index or the Dow Jones Industrial Average Index.*

*Investment in the Fund is subject to investment risks, including the possible loss of some or all of the principal amount invested. There can be no assurance that the Fund will be successful in meeting its investment objective. The Fund is intended for aggressive investors seeking above-average gains and willing to accept the risks involved in investing in equity securities. Investment in the Fund is also subject to, among other things, large-cap securities risk, mid-cap securities risk, small-cap securities risk, derivative instruments risk and short sales risk. More information about these risks and other risks can be found in the Fund's prospectus.*

*Statements in this Annual Report that reflect projections or expectations of future financial or economic performance of the Fund and of the market in general and statements of the Fund's plans and objectives for future operations are forward-looking statements. No assurance can be given that actual results or events will not differ materially from those projected, estimated, assumed or anticipated in any such forward-looking statements. Important factors that could result in such differences in addition to the other factors noted with such forward-looking statements include general economic conditions such as inflation, recession and interest rates. Past performance is not a guarantee of future results.*

**2022 Annual Report 2**

------

**<u>WELLINGTON SHIELDS ALL-CAP FUND (Unaudited)</u>**

**PERFORMANCE INFORMATION** ![](wellingtonn-csr11302022x5x1.jpg) <br>

**AVERAGE ANNUAL TOTAL RATE OF RETURN (%) FOR THE PERIODS ENDED NOVEMBER 30, 2022.**

---

| | | | |
|:---|:---|:---|:---|
|  | **<u>1 Year</u>** | **<u>5 Year</u>** | **<u>10 Year</u>** |
| **Wellington Shields All-Cap Fund – Institutional Shares** | (15.25)% | &nbsp;&nbsp;&nbsp;&nbsp;5.64% | &nbsp;&nbsp;&nbsp;&nbsp;9.69% |
| Russell 1000® Index | (10.66)% | 10.69% | 13.17% |
| S&P 500® Total Return Index | &nbsp;&nbsp;&nbsp;&nbsp;(9.21)% | 10.98% | 13.34% |

---

The performance information quoted in this annual report assumes the reinvestment of all dividend and capital gain distributions, if any, and represents past performance, which is not a guarantee of future results. The returns shown do not reflect taxes that a shareholder would pay on Fund distributions or on the redemption of Fund shares. The investment return and principal value of an investment will fluctuate and, therefore, an investor's shares, when redeemed, may be worth more or less than their original cost. Updated performance data current to the most recent month-end can be obtained by calling 1-888-626-3863. The Fund's Distributor is Wellington Shields & Co., LLC and the Fund's Sub-Distributor is Arbor Court Capital, LLC.

The above graph depicts the performance of the Wellington Shields All-Cap Fund - Institutional Shares versus the Russell 1000® Index and the S&P 500® Total Return Index. The Russell 1000® Index is an index of approximately 1,000 of the largest companies in the U.S. equity market. The Russell 1000® Index is a subset of the Russell 3000® Index. It represents the top companies by market capitalization. The S&P 500® Total Return Index by Standard & Poor's Corp. is a capitalization-weighted index comprising 500 issues listed on various exchanges, representing the performance of the stock market generally. Please note that indices do not take into account any fees and expenses of investing in the individual securities that they track and individuals cannot invest directly in any index.

As with any fund that commonly compares its performance to the Russell 1000® Index and S&P 500® Total Return Index, such a comparison may be said to be inappropriate because of the dissimilarity between the Fund's investments and the securities comprising the indices; so too with the Wellington Shields All-Cap Fund -Institutional Shares, which will not invest in certain securities comprising these indices.

**2022 Annual Report 3**

------

**<u>WELLINGTON SHIELDS ALL-CAP FUND (Unaudited)</u>**

**Disclosure of Expenses**

As a shareholder of the Fund, you incur ongoing costs, including management fees and other Fund expenses. Although the Fund charges no sales loads or transaction fees, you will be assessed fees for outgoing wire transfers, returned checks, and stop payment orders at prevailing rates charged by Mutual Shareholder Services, LLC, the Fund's transfer agent and IRA accounts will be charged an $8.00 annual maintenance fee. This Example is intended to help you understand your ongoing costs (in dollars) of investing in the Fund and to compare these costs with the ongoing costs of investing in other mutual funds.

The Example is based on an investment of $1,000 invested at the beginning of the period and held for the entire period June 1, 2022 through November 30, 2022.

The first line of the table below provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line under the heading entitled "Expenses Paid During Period" to estimate the expenses you paid on your account during this period.

The second line of the table below provides information about hypothetical account values and hypothetical expenses based on the Fund's actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Fund's actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in this Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds.

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transactional costs, such as IRA maintenance fees described above and expenses of any underlying funds. Therefore, the second line of the table is useful in comparing ongoing costs only, and will not help you determine the relative cost of owning different funds. In addition, if these transactional costs and expenses of underlying funds were included, your cost could have been higher.

---

| | | | |
|:---|:---|:---|:---|
| **<u>Institutional Shares</u>** |  |  |  |
|  |  |  | Expenses Paid |
|  | Beginning | Ending | During the Period\* |
|  | Account Value | Account Value | June 1, 2022 to |
|  | <u>June 1, 2022</u> | <u>November 30, 2022</u> | <u>November 30, 2022</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Actual | $1000.00 | $959.53 | $6.44 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hypothetical | $1000.00 | $1018.50 | $6.63 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5% annual return |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;before expenses) |  |  |  |

---

\* Expenses are equal to the Fund's annualized expense ratio of 1.31% for the Institutional Shares, multiplied by the average account value over the period, multiplied by 183/365 (to reflect the one-half year period.)

**Total Annual Fund Operating Expense Ratio**

The Total Annual Fund Operating Expense Ratio as stated in the Fund's current prospectus dated March 30, 2022 was 1.33% .

*The Total Annual Fund Operating Expense Ratio reported above may not correlate to the expense ratio in the Fund's financial highlights because (a) the financial highlights include only the direct operating expenses incurred by the Fund, not the indirect costs of investing in acquired funds, and (b) the gross expense ratio may fluctuate due to changes in net assets and actual expenses incurred during the reported period.*

**<br> 2022 Annual Report 4**

------

---

| | | |
|:---|:---|:---|
| **Wellington Shields All-Cap Fund** | | |
|  | **Schedule of Investments** | **Schedule of Investments** |
| | **November 30, 2022** | **November 30, 2022** |
| **Shares** | **Fair Value** | **% of Net Assets** |
| **COMMON STOCKS** |  |  |
| **Aerospace & Defense** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5,000 Curtiss-Wright Corporation | $883250 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2,000 Lockheed Martin Corporation | 970380 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,600 Northrop Grumman Corporation | 853264 |  |
|  | 2706894 | 5.22% |
| **Banks** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7,500 First Republic Bank | 957075 | 1.85% |
| **Beverages** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9,000 The Coca-Cola Company | 572490 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5,000 Constellation Brands, Inc. - Class A | 1286750 |  |
|  | 1859240 | 3.59% |
| **Capital Markets** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4,400 Blackstone Inc. | 402732 | 0.78% |
| **Chemicals** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5,000 Linde PLC (United Kingdom) | 1682400 | 3.25% |
| **Crude Petroleum & Natural Gas** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16,000 Diamondback Energy, Inc. | 2368320 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8,000 Pioneer Natural Resources Company | 1887920 |  |
|  | 4256240 | 8.21% |
| **Electric Utilities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23,000 Constellation Energy Corporation | 2210760 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17,100 NextEra Energy, Inc. | 1448370 |  |
|  | 3659130 | 7.06% |
| **Electrical Equipment** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14,000 Emerson Electric Co. | 1340780 | 2.59% |
| **Electronic Computers** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6,000 Apple Inc. | 888180 | 1.71% |
| **Fabricated Plate Work (Boiler Shops)** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9,000 Chart Industries, Inc. \* | 1286910 | 2.48% |
| **Farm Machinery & Equipment** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4,300 Deere & Company | 1896300 | 3.66% |
| **Food & Staples Retailing** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3,400 Walmart Inc. | 518228 | 1.00% |
| **Health Care Equipment & Supplies** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11,400 Edwards Lifesciences Corporation \* | 880650 | 1.70% |
| **Health Care Providers & Services** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4,800 McKesson Corporation | 1832064 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,850 UnitedHealth Group Incorporated | 1013356 |  |
|  | 2845420 | 5.49% |
| **Hotels, Restaurants & Leisure** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,800 McDonald's Corporation | 491022 | 0.95% |
| **Industrial Conglomerates** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6,500 Honeywell International Inc. | 1427075 | 2.75% |
| **Internet & Direct Marketing Retail** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12,000 Alphabet, Inc. - Class A \* | 1211880 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9,600 Amazon.com, Inc. \* | 926784 |  |
|  | 2138664 | 4.13% |
| **IT Services** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3,650 Accenture PLC - Class A (United Kingdom) | 1098395 | 2.12% |
| **Life Sciences Tools & Services** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,500 Thermo Fisher Scientific Inc. | 840330 | 1.62% |
| **Multiline Retail** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6,500 Target Corporation | 1085955 | 2.10% |
| **Oil, Gas & Consumable Fuels** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5,000 Cheniere Energy, Inc | 876800 | 1.69% |

---

\* Non-Income Producing Securities.<br>The accompanying notes are an integral part of these<br> financial statements.

**2022 Annual Report 5**

------

---

| | | |
|:---|:---|:---|
| **Wellington Shields All-Cap Fund** | **Wellington Shields All-Cap Fund** | **Wellington Shields All-Cap Fund** |
|  | **Schedule of Investments** | **Schedule of Investments** |
| | **November 30, 2022** | **November 30, 2022** |
| **Shares** | **Fair Value** | **% of Net Assets** |
| **COMMON STOCKS** |  |  |
| **Pharmaceuticals** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3,500 Eli Lilly And Company | $1298780 | 2.51% |
| **Semiconductors & Semiconductor Equipment** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4,000 Enphase Energy Inc. \* | 1282360 | 2.47% |
| **Software** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5,500 Microsoft Corporation | 1403270 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3,000 Palo Alto Networks, Inc. \* | 509700 |  |
|  | 1912970 | 3.69% |
| **Transportation Services** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12,000 GXO Logistics, Inc. \* | 562320 | 1.09% |
| **Total for Common Stocks (Cost $29,402,734)** | 38194850 | 73.71% |
| **EXCHANGE TRADED FUNDS** |  |  |
| **Equity Funds** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3,000 iShares® U.S. Consumer Staples ETF | 624840 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10,000 The Health Care Select Sector SPDR® Fund | 1390200 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8,500 SPDR® S&P® Oil & Gas Exploration & Production ETF | 1293020 |  |
|  | 3308060 |  |
| **Total Exchange Traded Funds (Cost $2,569,946)** | 3308060 | 6.38% |
| **MONEY MARKET FUNDS** |  |  |
| 10,245,537 First American Treasury Obligations Fund - |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class X 3.75% \*\* | 10245537 |  |
| **Total Money Market Funds (Cost $10,245,537)** | 10245537 | 19.77% |
| **Investments at Fair Value (Cost $42,218,217)** | 51748447 | 99.86% |
| **Other Assets in Excess of Liabilities** | 70659 | 0.14% |
| **Net Assets** | $51819106 | 100.00% |

---

---

| | | |
|:---|:---|:---|
| **SCHEDULE OF INVESTMENTS BY SECTOR as of November 30, 2022 (Unaudited)** | **SCHEDULE OF INVESTMENTS BY SECTOR as of November 30, 2022 (Unaudited)** |  |
|  |  | **% of Net** |
|  | **Fair Value** | **Assets** |
| Industrials | $9220279 | 17.79% |
| Health Care | 5865180 | 11.32% |
| Information Technology | 5181905 | 10.00% |
| Energy | 5133040 | 9.91% |
| Consumer Discretionary | 3715641 | 7.17% |
| Utilities | 3659130 | 7.06% |
| Exchange Traded Funds | 3308060 | 6.38% |
| Consumer Staples | 2377468 | 4.59% |
| Materials | 1682400 | 3.25% |
| Financials | 1359807 | 2.62% |
|  | $41502910 | 80.09% |

---

\* Non-Income Producing Securities.<br> \*\* The rate shown represents the 7-day yield at November 30, 2022.<br>The accompanying notes are an integral part of these<br> financial statements.

**2022 Annual Report 6**

------

---

| | |
|:---|:---|
| **Wellington Shields All-Cap Fund** | |
| **Statement of Assets and Liabilities** |  |
| **November 30, 2022** |  |
| Assets: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investments at Fair Value | $51748447 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Cost $42,218,217) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash | 309 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid Expenses | 5350 |
| Receivables: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends | 132318 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Assets | 51886424 |
| Liabilities: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Advisory Fees Payable | 41747 |
| &nbsp;&nbsp;&nbsp;&nbsp;Administration Fees Payable | 3071 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Accrued Expenses | 22500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Liabilities | 67318 |
| Net Assets | $51819106 |
| Net Assets Consist of: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Paid In Capital (par value and paid in surplus) | $41099397 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Distributable Earnings | 10719709 |
| Net Assets | $51819106 |
| Institutional Shares |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net Assets | $51819106 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Institutional Shares Outstanding, $0.01 par value (unlimited shares authorized) | 2252572 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net Asset Value, Maximum Offering Price and Redemption Price Per Share | $23.00 |
| **Statement of Operations** |  |
| **For the fiscal year ended November 30, 2022** |  |
| Investment Income: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends (Net of foreign withholding tax of $911) | $1065513 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Investment Income | 1065513 |
| Expenses: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Management Fees | 542642 |
| &nbsp;&nbsp;&nbsp;&nbsp;Transfer Agent Fees & Accounting Fees | 45753 |
| &nbsp;&nbsp;&nbsp;&nbsp;Administration Fees | 37985 |
| &nbsp;&nbsp;&nbsp;&nbsp;Legal Fees | 25708 |
| &nbsp;&nbsp;&nbsp;&nbsp;Audit Fees | 15912 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trustees Fees | 12042 |
| &nbsp;&nbsp;&nbsp;&nbsp;Miscellaneous Expense | 8085 |
| &nbsp;&nbsp;&nbsp;&nbsp;Custody Fees | 6552 |
| &nbsp;&nbsp;&nbsp;&nbsp;Insurance Expense | 4452 |
| &nbsp;&nbsp;&nbsp;&nbsp;Registration Expense | 4201 |
| &nbsp;&nbsp;&nbsp;&nbsp;Printing and Postage Expense | 1116 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Expenses | 704448 |
| Net Investment Income | 361065 |
| Net Realized and Unrealized Gain/(Loss) on Investments: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net Realized Gain on Investments | 3661516 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net Change In Unrealized Appreciation on Investments | (13392503) |
| Net Realized and Unrealized Loss on Investments | (9730987) |
| Net Decrease in Net Assets from Operations | $(9369922) |

---

The accompanying notes are an integral part of these<br> financial statements.

**2022 Annual Report 7**

------

---

| | | |
|:---|:---|:---|
| **Wellington Shields All-Cap Fund** | **Wellington Shields All-Cap Fund** | **Wellington Shields All-Cap Fund** |
| **Statements of Changes in Net Assets** |  |  |
|  | Year Ended | Year Ended |
|  | 11/30/2022 | 11/30/2021 |
| From Operations: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net Investment Income / (Loss) | $361065 | $(357412) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net Realized Gain on Investments | 3661516 | 5399737 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net Change in Unrealized Appreciation on Investments | (13392503) | 8205841 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net Increase / (Decrease) in Net Assets from Operations | (9369922) | 13248166 |
| From Distributions to Shareholders: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Institutional Shares | (3654166) | (5265216) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in Net Assets from Distributions | (3654166) | (5265216) |
| From Capital Share Transactions: |  |  |
| *Institutional Shares* |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Shares Sold | 265324 | 388097 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reinvested Distributions | 3607143 | 5181637 |
| &nbsp;&nbsp;&nbsp;&nbsp;Shares Repurchased | (784339) | (1780087) |
| Net Increase from Capital Share Transactions | 3088128 | 3789647 |
| Net Increase / (Decrease) in Net Assets | (9935960) | 11772597 |
| Net Assets at Beginning of Year | 61755066 | 49982469 |
| Net Assets at End of Year | $51819106 | $61755066 |
| Share Transactions: |  |  |
| *Institutional Shares* |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Shares Sold | 10567 | 13865 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reinvested Distributions | 157862 | 171748 |
| &nbsp;&nbsp;&nbsp;&nbsp;Shares Repurchased | (30124) | (63749) |
| Net Increase in Shares | 138305 | 121864 |

---

The accompanying notes are an integral part of these<br> financial statements.

**2022 Annual Report 8**

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Wellington Shields All-Cap Fund** | **Wellington Shields All-Cap Fund** | **Wellington Shields All-Cap Fund** | **Wellington Shields All-Cap Fund** | **Wellington Shields All-Cap Fund** | **Wellington Shields All-Cap Fund** |
| **Financial Highlights** |  |  |  |  |  |
| Selected data for a share outstanding |  |  |  |  |  |
| throughout each period: | Year Ended | Year Ended | Year Ended | Year Ended | Year Ended |
|  | 11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 | 11/30/2018 |
| Net Asset Value - |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Beginning of Year | $29.21 | $25.09 | $21.84 | $21.00 | $23.59 |
| Net Investment Income / (Loss) *(a)* | 0.17 | (0.18) | (0.12) | (0.03) | (0.12) |
| Net Gain (Loss) on Investments |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;(realized and unrealized) | (4.64) | 7.01 | 3.43 | 2.54 | (1.11) |
| Total from Investment Operations | (4.47) | 6.83 | 3.31 | 2.51 | (1.23) |
| Distributions (From Net Investment Income) | (0.13) |  |  |  |  |
| Distributions (From Net Realized Gains) | (1.61) | (2.71) | (0.06) | (1.67) | (1.36) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Distributions | (1.74) | (2.71) | (0.06) | (1.67) | (1.36) |
| Net Asset Value - |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;End of Year | $23.00 | $29.21 | $25.09 | $21.84 | $21.00 |
| Total Return *(b)* | (15.25)% | 26.88% | 15.15% | 12.03% | (5.18)% |
| Ratios/Supplemental Data |  |  |  |  |  |
| Net Assets - End of Year (Thousands) | $51819 | $61755 | $49982 | $44742 | $29303 |
| Before Waiver/Reimbursement/Recoupment |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Ratio of Expenses to Average Net Assets *(c)* | 1.30% | 1.28% | 1.33% | 1.64% | 1.60% |
| After Waiver/Reimbursement/Recoupment |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Ratio of Expenses to Average Net Assets *(c)* | 1.30% | 1.50% | 1.50% | 1.50% | 1.49% |
| &nbsp;&nbsp;&nbsp;&nbsp;Ratio of Net Investment Income / (Loss) to |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Average Net Assets | 0.67% | (0.64)% | (0.55)% | (0.12)% | (0.50)% |
| Portfolio Turnover Rate | 74.35% | 45.90% | 74.46% | 88.33% *(d)* | 74.94% |

---

(a) Based on Average Shares Outstanding.<br> (b) Total return represents the rate that the investor would have earned or lost on an investment in the Fund<br> assuming reinvestment of dividends.<br> (c) The expense ratios reflect total expenses prior to any waivers, reimbursements and recoupments (gross<br> expense ratios) and after any waivers, reimbursements and recoupments (net expense ratios).<br> (d) The calculation of portfolio turnover excluded sales totaling $575,280 which occurred to realign the<br> Fund's portfolio following a fund merger which went effective as of the close of business on November 25,<br> 2019.

The accompanying notes are an integral part of these<br> financial statements.

**2022 Annual Report 9**

------

**NOTES TO FINANCIAL STATEMENTS**<br> **WELLINGTON SHIELDS ALL-CAP FUND**<br> **November 30, 2022**

<br> 1. ORGANIZATION<br> Wellington Shields All-Cap Fund (the "Fund") is a diversified series of the Capital Management Investment Trust (the "Trust"), a registered open-end management investment company. The Trust was organized on October 14, 1994, as a Massachusetts business trust and may offer shares of beneficial interest in a number of separate series, each series representing a distinct fund with its own investment objectives and policies. As of November 30, 2022, there is one series authorized by the Trust. Prior to March 29, 2018, the Fund was known as the Capital Management Mid-Cap Fund. The Fund's investment adviser is Capital Management Associates, Inc. ("CMA" or "Advisor"). The Fund currently offers Institutional shares. The Fund commenced operations on January 27, 1995. The investment objective of the Fund is to seek capital appreciation.

2. SIGNIFICANT ACCOUNTING POLICIES<br> The following accounting policies have been consistently followed by the Fund and are in conformity with accounting principles generally accepted in the United States of America ("GAAP") in the investment company industry. The Fund is an investment company that follows the accounting and reporting guidance of Accounting Standards Codification Topic 946 applicable to investment companies.

*INVESTMENT VALUATION*<br> All investments in securities are recorded at their estimated fair value, as described in Note 3.

*SHARE VALUATION*<br> The net asset value (the "NAV") is generally calculated as of the close of trading on the New York Stock Exchange (the "Exchange") (normally 4:00 p.m. Eastern time) every day the Exchange is open. The NAV is calculated by taking the total value of the Fund's assets, subtracting its liabilities, and then dividing by the total number of shares outstanding, rounded to the nearest cent. The offering price and redemption price per share is equal to the net asset value per share.

*INVESTMENT TRANSACTIONS AND INVESTMENT INCOME*<br> Investment transactions are accounted for as of the date purchased or sold (trade date). Dividend income is recorded on the ex-dividend date. Certain dividends from foreign securities will be recorded as soon as the Trust is informed of the dividend if such information is obtained subsequent to the ex-dividend date. Interest income, if any, is recorded on the accrual basis and includes amortization of discounts and premiums. Gains and losses are determined on the identified cost basis, which is the same basis used for federal income tax purposes.

*WRITTEN OPTIONS*<br> The Fund may write covered call options on equity securities or futures contracts that the Fund is eligible to purchase to earn premium income, to assure a definite price for a security it has considered selling, or to close out options previously purchased. The Fund may write covered call options if, immediately thereafter, not more than 30% of its net assets would be committed to such transactions. A call option gives the holder (buyer) the right to purchase a security or futures contract at a specified price (the exercise price) at any time until a certain date (the expiration date). A call option is "covered" if the Fund owns the underlying security subject to the call option at all times during the option period. When the Fund writes a covered call option, it maintains in a segregated account with its custodian or as otherwise required by the rules of the exchange for the underlying security, cash or liquid portfolio securities in an amount not less than the exercise price at all times while the option is outstanding.

The writing of covered call options is considered to be a conservative investment technique. The Fund will receive a premium from writing a call option, which increases the Fund's return in the event the option expires unexercised or is closed out at a profit. The amount of the premium will reflect, among other things, the relationship of the market price of the underlying security to the exercise price of the option and the remaining term of the option. However, there is no assurance that a closing transaction can be effected at a favorable price. During the option period, the covered call writer has, in return for the premium received, given up the opportunity for capital appreciation above the exercise price should the market price of the underlying security increase, but has retained the risk of loss should the price of the underlying security decline.

*DIVIDEND DISTRIBUTIONS*<br> Dividends paid by the Fund derived from net investment income (if any) will generally be paid annually. Distributions from capital gains (if any) are generally declared and distributed annually. The Fund may also make a supplemental distribution subsequent to the end of its fiscal year. Dividends and distributions to shareholders are recorded on the ex-dividend date.

**2022 Annual Report 10**

------

**Notes to Financial Statements - continued**

*ESTIMATES*<br> The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in the net assets from operations during the reported year. Actual results could differ from those estimates.

*FEDERAL INCOME TAXES*<br> The Fund is considered a personal holding company as defined under Section 542 of the Internal Revenue Code since 50% of the value of the Fund's shares were owned directly or indirectly by five or fewer individuals at certain times during the last half of the year. As a personal holding company, a 20% tax would be imposed for each tax year on undistributed personal holding company income. Generally, provisions for income taxes are not included in the financial statements as the Fund intends to distribute to shareholders all taxable investment income and realized gains and otherwise comply with Subchapter M of the Internal Revenue Code applicable to regulated investment companies.

As of and during the fiscal year ended November 30, 2022, the Fund did not have a liability for any unrecognized tax expense. The Fund recognizes interest and penalties, if any, related to unrecognized tax expense as income tax expense in the Statement of Operations. As of November 30, 2022, the Fund did not incur any interest or penalties. As required, management has analyzed the Fund's tax positions taken on Federal income tax returns for all open tax years and expected to be taken during the fiscal year ended November 30, 2022, and has concluded that no provision for income tax is required in these financial statements.

3. SECURITIES VALUATIONS<br> The Fund utilizes various methods to measure the fair value of most of its investments on a recurring basis. GAAP establishes a hierarchy that prioritizes inputs to valuation methods. The three levels of inputs are:

Level 1 - Unadjusted quoted prices in active markets for identical assets or liabilities that the Fund has the ability to access.

Level 2 - Inputs other than quoted prices included in level 1 that are observable for the asset or liability, either directly or indirectly. These inputs may include quoted prices for the identical instrument on an inactive market, prices for similar instruments, interest rates, prepayment speeds, credit risk, yield curves, default rates and similar data.

Level 3 - Unobservable inputs for the asset or liability, to the extent relevant observable inputs are not available, representing the Fund's own assumptions about the assumptions a market participant would use in valuing the asset or liability, and would be based on the best information available.

The availability of observable inputs can vary from security to security and is affected by a wide variety of factors, including, for example, the type of security, whether the security is new and not yet established in the marketplace, the liquidity of markets, and other characteristics particular to the security. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in level 3.

The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement falls in its entirety, is determined based on the lowest level input that is significant to the fair value measurement in its entirety.

*FAIR VALUE MEASUREMENTS*<br> A description of the valuation techniques applied to the Fund's major categories of assets and liabilities measured at fair value on a recurring basis follows.

*Equity securities (common stocks and exchange traded funds).* Equity securities generally are valued by using market quotations but may be valued on the basis of prices furnished by a pricing service when the Valuation Designee believes such prices accurately reflect the fair market value of such securities. Securities that are traded on any stock exchange or on the NASDAQ over-the-counter market are generally valued by the pricing service at the last quoted sale price on the primary exchange or market on which the security trades. Lacking a last sale price, an equity security is generally valued by the pricing service at its last bid price. In the event of a short sale of an equity security, lacking a last sale price, an equity security is generally valued by the pricing service at its last ask price. Generally, if the security is traded in an active market and is valued at the last sale price, the security is categorized as a level 1 security, and if an equity security is valued by the

**2022 Annual Report 11**

------

**Notes to Financial Statements - continued** 

pricing service at its last bid price, it is generally categorized as a level 2 security. When market quotations are not readily available or when the Valuation Designee determines that the market quotation or the price provided by the pricing service does not accurately reflect the current market value, or when restricted or illiquid securities are being valued, such securities are valued pursuant to the fair value pricing procedures.

*Money market funds.* Shares of money market funds are valued at net asset value provided by the underlying fund and are classified in level 1 of the fair value hierarchy.

*Derivatives.* Listed derivatives, including purchased options and written options, that are actively traded, are valued based on quoted prices from the primary exchange on which the option trades. To the extent these derivatives are actively traded and valuation adjustments are not applied, they are classified in level 1 of the fair value hierarchy. Options held by the Fund that are not traded on the valuation date will be valued at the mean of the bid and ask price on the primary exchange on which the option trades. If there is not a bid and ask price on the primary exchange on which the option trades, the option will be valued at fair value as determined under the fair value pricing procedures. When the mean price is used for valuation or when the derivative is not actively traded, those securities are generally categorized in level 2 of the fair value hierarchy.

In accordance with the Trust's good faith pricing guidelines, the Valuation Committee, which includes the Valuation Designee, shall consider all appropriate factors relevant to the value of securities for which market quotations are not readily available. There is no single standard for determining fair value, since fair value depends upon the circumstances of each individual case. As a general principle, the current fair value of an issue of securities being valued by the Valuation Committee would appear to be the price at which the security could reasonably be sold in a current market transaction. Methods which are in accordance with this principle may, for example, be based on (i) a multiple of earnings; (ii) a discount from market of a similar freely traded security (including a derivative security or a basket of securities traded on other markets, exchanges or among dealers); or (iii) yield to maturity with respect to debt issues, or a combination of these and other methods.

The following table summarizes the inputs used to value the Fund's assets measured at fair value as of November 30, 2022:

---

| | | | | |
|:---|:---|:---|:---|:---|
| <u>Valuation Inputs of Assets</u> | <u>Level 1</u> | <u>Level 2</u> | <u>Level 3</u> | <u>Total</u> |
| Common Stocks | $38194850 | $– | $– | $38194850 |
| Exchange Traded Funds | 3308060 | &nbsp;&nbsp;&nbsp;&nbsp;– | &nbsp;&nbsp;&nbsp;&nbsp;– | 3308060 |
| Money Market Funds | <u>10245537</u> | <u>–</u> | <u>–</u> | <u>10245537</u> |
| Total | $51748447 | $– | $– | $51748447 |

---

Refer to the Fund's Schedule of Investments for a listing of securities by industry. The Fund did not hold any Level 3 assets or liabilities during the fiscal year ended November 30, 2022.

During the fiscal year ended November 30, 2022, there were no derivative transactions in the Fund.

4. INVESTMENT ADVISORY AGREEMENT<br> The Trust, on behalf of the Fund, has entered into an Investment Advisory Agreement with CMA. Under the terms of the Investment Advisory Agreement, the Advisor manages the investment portfolio of the Fund, subject to policies adopted by the Trust's Board of Trustees. Under the Investment Advisory Agreement, the Advisor provides guidance and policy direction in connection with its daily management of the Fund's assets. The Advisor manages the investment and reinvestment of the Fund's assets. The Advisor is also responsible for the selection of broker-dealers through which the Fund executes portfolio transactions, subject to the brokerage policies established by the Trustees, and it provides certain executive personnel to the Fund.

The Advisor earns an annual management fee of 1.00% of the Fund's first $100 million of the Fund's net assets, 0.90% of the next $150 million, 0.85% of the next $250 million and 0.80% of all assets over $500 million. For the fiscal year ended November 30, 2022, the Advisor earned management fees totaling $542,642 before the waiver of management fees and reimbursement of expenses described below. As of November 30, 2022, the Fund owed the Advisor $41,747. The Advisor has agreed to waive or limit its fees and to assume other expenses so that the total annual operating expenses of the Fund (other than interest, taxes, brokerage commissions, other expenditures that are capitalized in accordance with generally accepted accounting principles, other extraordinary expenses not incurred in the ordinary course of each Fund's business, Acquired Fund Fees and Expenses and amounts, if any, payable pursuant to a Rule 12b-1 Plan) are limited to 1.50% of the average daily net assets of the Fund through the period ending April 1, 2023 ("Expense Limitation Agreement"). It is expected that the Expense Limitation Agreement will continue from year-to-year thereafter, provided such continuance is specifically approved by a majority of the Trustees who (i) are not "interested persons" of the Trust or any other party to the Expense

**2022 Annual Report 12**

------

**Notes to Financial Statements - continued**

Limitation Agreement, as defined in the Investment Company Act of 1940, as amended ("1940 Act"); and (ii) have no direct or indirect financial interest in the operation of this Expense Limitation Agreement. The Expense Limitation Agreement may also be terminated by the Advisor and the Trust at the end of the then current term upon not less than 90-days' notice to the other party as set forth in the Expense Limitation Agreement.

The Fund may, at a later date, reimburse the Advisor the management fees waived or limited and other expenses assumed and paid by the Advisor pursuant to the Expense Limitation Agreement for a period of three years from the date of the actual waiver or expense reimbursement, provided the Fund has reached a sufficient asset size to permit such reimbursement to be made without causing the total annual expense ratio of the Fund to exceed the percentage limits stated above. Consequently, no reimbursement by the Fund will be made unless: (i) the Fund's assets exceed $10 million; (ii) the Fund's total annual expense ratio is less than the percentage limit stated above; and (iii) the payment of such reimbursement has been approved by the Trustees on a quarterly basis. The Advisor may recoup fees and expenses waived or reimbursed for the Wellington Shields Small-Cap Fund prior to its reorganization into the Fund, and fees and expenses waived or reimbursed for the Fund after the reorganization, which occurred as of the close of business on November 25, 2019. In accordance with the Expense Limitation Agreement, there were $68,962 of fees available for recoupment through November 30, 2022; however, the Advisor waived its recoupment rights for the remaining $68,962 related to the fiscal year 2022. Certain officers and directors of the Advisor are also officers and/or Trustees of the Trust.

5. OTHER TRANSACTIONS WITH AFFILIATES<br> *Distributor*<br> Wellington Shields & Co., LLC (the "Distributor") is the Fund's principal underwriter and distributor. The Distributor is also the introducing broker-dealer and is used by the Fund for its investment transactions. For the fiscal year ended November 30, 2022, there were commissions on investment transactions paid to the Distributor of $8,374. Certain Trustees and officers of the Trust are also officers of the Distributor.

*Administrator*<br> Premier Fund Solutions, Inc. ("PFS" or "Administrator") serves as the Administrator for the Trust pursuant to a written agreement with the Trust. PFS provides day-to-day administrative services to the Fund. For PFS's services to the Fund, the Fund pays PFS an annualized asset-based fee of 0.07% of average daily net assets up to $200 million, with lower rates at higher asset levels, subject to a minimum monthly fee of $2,500, plus reimbursement of out-of-pocket expenses. For its services, during the fiscal year ended November 30, 2022, PFS earned $37,985. Certain officers of the Trust are also officers of the Administrator.

6. PURCHASES AND SALES OF INVESTMENT SECURITIES<br> For the fiscal year ended November 30, 2022, purchases and sales of investment securities other than U.S. Government obligations and short-term investments aggregated $35,908,588 and $44,733,208, respectively. Purchases and sales of U.S. Government obligations aggregated $0 and $0, respectively.

7. CONTROL OWNERSHIP<br> The beneficial ownership, either directly or indirectly, of more than 25% of the voting shares of a fund creates a presumption of control of the fund, under Section 2(a)(9) of the Investment Company Act of 1940. As of November 30, 2022, First Clearing Corporation, A/C 204, Wells Fargo Clearing Services, owned of record approximately 27.47% of the Fund and therefore, may be deemed to control the Fund.

8. TAX MATTERS<br> For Federal income tax purposes, the cost of investments owned at November 30, 2022, was $42,218,217.

At November 30, 2022, the composition of gross unrealized appreciation (the excess of value over tax cost) and depreciation (the excess of tax cost over value) of investments (including open positions in options written) on a tax basis was as follows:

---

| | | |
|:---|:---|:---|
| <u>Appreciation</u> | <u>(Depreciation)</u> | <u>Net Appreciation (Depreciation)</u> |
| $10067943 | ($537713) | $9530230 |

---

The tax character of distributions was as follows:

---

| | | |
|:---|:---|:---|
|  | Year ended | Year ended |
|  | <u>November 30, 2022</u> | <u>November 30, 2021</u> |
| Ordinary Income: | $376957 | $250708 |
| Long-term Capital Gain: | <u>3277209</u> | <u>5014508</u> |
|  | <u>$3654166</u> | <u>$5265216</u> |

---

**<br> 2022 Annual Report 13**

------

**Notes to Financial Statements - continued**

Subsequent to November 30, 2022, there was a dividend paid on December 28, 2022 to the shareholders of record on December 27, 2022, of $0.040435 per share.

As of November 30, 2022, the components of distributable earnings (accumulated losses) on a tax basis were as follows:

---

| | |
|:---|:---|
| Accumulated Undistributed Ordinary Income | &nbsp;&nbsp;&nbsp;&nbsp;$91065 |
| Other Accumulated Gains (Losses) | (3913) |
| Undistributed Long-Term Capital Gain (Accumulated Losses) | 1102327 |
| Unrealized Appreciation (Depreciation) - Net | <u>9530230</u> |
| Total Distributable Earnings | <u>$10719709</u> |

---

As of November 30, 2022, there were no differences between book basis and tax basis unrealized appreciation. As of November 30, 2022, other accumulated losses above are attributable to losses on straddles from options, which totaled $3,913.

9. COVID-19 RISKS<br> Unexpected local, regional or global events, such as war, acts of terrorism, financial, political or social disruptions, natural, environmental or man-made disasters, the spread of infectious illnesses or other public health issues, and recessions and depressions could have a significant impact on the Fund and its investments and may impair market liquidity. Such events can cause investor fear, which can adversely affect the economies of nations, regions and the market in general, in ways that cannot necessarily be foreseen. The impact of COVID-19 has adversely affected, and other infectious illness outbreaks that may arise in the future could adversely affect, the economies of many nations and the entire global economy, individual issuers and capital markets in ways that cannot necessarily be foreseen. Public health crises caused by the COVID-19 outbreak may exacerbate other pre-existing political, social and economic risks in certain countries or globally. The duration of the COVID-19 outbreak and its effects cannot be determined with certainty.

10. COMMITMENTS AND CONTINGENCIES<br> Under the Trust's organizational documents, its officers and Trustees are indemnified against certain liabilities arising out of the performance of their duties to the Fund. In addition, in the normal course of business, the Trust entered into contracts with its vendors, on behalf of the Fund, and others that provide for general indemnifications. The Fund's maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Fund. The Fund expects the risk of loss to be remote.

11. SUBSEQUENT EVENTS<br> Management has evaluated the impact of all subsequent events on the Fund through the date the financial statements were issued, and has determined that, other than the December 28, 2022 distributions reported in Note 8, there are no events requiring adjustment to or disclosure in the financial statements.

**2022 Annual Report 14**

------

**This page was intentionally left blank.**

**2022 Annual Report 15**

------

![](wellingtonn-csr11302022x18x1.jpg) <br>

**REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

**To the Board of Trustees of Capital Management Investment Trust <br> and the Shareholders of Wellington Shields All-Cap Fund**

**Opinion on the Financial Statements**<br> We have audited the accompanying statement of assets and liabilities of Wellington Shields All-Cap Fund, a series of shares of beneficial interest in Capital Management Investment Trust (the "Fund"), including the schedule of investments, as of November 30, 2022, and the related statement of operations for the year then ended, the statements of changes in net assets for each of the years in the two-year period then ended and the financial highlights for each of the years in the five-year period then ended, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Fund as of November 30, 2022, and the results of its operations for the year then ended, the changes in its net assets for each of the years in the two-year period then ended and its financial highlights for each of the years in the five-year period then ended, in conformity with accounting principles generally accepted in the United States of America.

**Basis for Opinion**<br> These financial statements are the responsibility of the Fund's management. Our responsibility is to express an opinion on the Fund's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (***"PCAOB"***) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities law and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Fund is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risk of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our procedures included confirmation of securities owned as of November 30, 2022 by correspondence with the custodian. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. ![](wellingtonn-csr11302022x18x2.jpg) <br>

**BBD, LLP**

*We have served as the auditor of one or more of the Funds in the Capital Management Investment Trust since 2006.*

**Philadelphia, Pennsylvania <br> January 18, 2023**

**2022 Annual Report 16**

------

**ADDITIONAL INFORMATION**<br> **November 30, 2022**<br> **(UNAUDITED)**

1. PROXY VOTING GUIDELINES<br> A copy of the Trust's Proxy Voting and Disclosure Policy and Advisor's Proxy Voting and Disclosure Policy are included as Appendix B to the Fund's Statement of Additional Information, which are available, without charge, upon request, by calling 1-888-626-3863 and on the SEC's website at http://www.sec.gov. Information regarding how the Fund voted proxies relating to portfolio securities during the most recent 12-month period ended June 30 is available (1) without charge, upon request, by calling the Fund at the number above and (2) on the SEC's website at http://www.sec.gov.

2. AVAILABILITY OF QUARTERLY SCHEDULE OF INVESTMENTS<br> The Fund publicly files its complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year on Form N-PORT. The Fund's Form N-PORT is available on the SEC's website at http://www.sec.gov. Copies of the Fund's Form N-PORT are also available, without charge, by calling the Fund at 1-888-626-3863.

3. TAX INFORMATION<br> We are required to advise you within 60 days of the Fund's fiscal year-end regarding the federal tax status of certain distributions received by shareholders during each fiscal year. As of the Fund's fiscal year ended November 30, 2022, there was an ordinary income distribution paid in the amount of $376,957 and a long-term capital gain distribution paid in the amount of $3,277,209.

Individual shareholders are eligible for reduced tax rates on qualified dividend income. For the purposes of computing the dividends eligible for reduced tax rates, all of the dividends paid by the fund from ordinary income earned during the fiscal year are considered qualified dividend income.

Corporate shareholders may exclude up to 70% of qualifying dividends. For the purposes of computing this exclusion, all of the dividends paid by the funds from ordinary income earned during the fiscal year represent qualifying dividends.

Dividends and distributions received by retirement plans such as IRAs, Keogh-type plans and 403(b) plans need not be reported as taxable income. However, many retirement plans may need this information for their annual information reporting.

The tax information above is reported from the Fund's fiscal year and not calendar year, therefore, shareholders should refer to their Form 1099-DIV or other tax information which will be mailed in 2023 to determine the calendar year amounts to be included on their 2022 tax returns. Shareholders should consult their own tax advisors.

4. ANNUAL RENEWAL OF THE CURRENT AGREEMENT FOR THE FUND<br> At a meeting held on October 12, 2022 (the "Meeting"), the Board considered the approval of the Fund's current investment advisory agreement, the Second Amended and Restated Investment Advisory Agreement (the "Current Advisory Agreement") and a new Investment Advisory Agreement (the "New Advisory Agreement"), each between the Trust and Capital Management Associates, Inc. ("CMA") with respect to the Wellington Shields All-Cap Fund (the "Fund"). The Current Advisory Agreement and the New Advisory Agreement will be referred to herein collectively as the "Advisory Agreements." The Board considered that it had approved the New Advisory Agreement at its July 31, 2019 meeting in anticipation of a technical change in control of CMA, the Fund's investment adviser, expected to occur upon the distribution of Mr. Joseph V. Shields Jr.'s ownership interest in CMA from his estate, at which time the Fund's Current Advisory Agreement would terminate pursuant to Section 15(a)(4) of the Investment Company Act of 1940. It was noted that the New Advisory Agreement was approved by shareholders of the Fund at a Special Meeting of Shareholders held on November 22, 2019. The Trustees considered that the Board was asked to approve the renewal of the Current Advisory Agreement at the Meeting because Mr. Joseph V. Shields Jr.'s ownership interest in CMA remained in his estate and the New Advisory Agreement was therefore not yet in effect. The Trustees further considered that the Board is also being asked to re-approve the New Advisory Agreement because of the length of time that has passed since its initial approval. The Board noted that CMA reported that, according it does not know when the ownership interest will be released and the change in control will occur.

The Board considered a memorandum from counsel to the Trust ("Counsel") and addressed to the Board that summarized, among other things, the fiduciary duties and responsibilities of the

**2022 Annual Report 17**

------

**Additional Information (Unaudited) - continued**

Board in reviewing and approving the Advisory Agreements. The Trustees discussed the types of information and factors that should be considered by the Board in order to make an informed decision regarding the approval of the Advisory Agreements, including the following material factors: (i) the nature, extent and quality of the services provided by CMA; (ii) the investment performance of the Fund; (iii) the costs of the services provided and profits realized by CMA from the relationship with the Fund; (iv) the extent to which economies of scale would be realized if the Fund grows and whether advisory fee levels reflect those economies of scale for the benefit of the investors of the Fund; and (v) CMA's practices regarding possible conflicts of interest and other benefits derived by CMA.

In assessing these factors and reaching its decisions, the Board took into consideration information furnished for the Board's review and consideration throughout the year at regular Board meetings, including information presented to the Board in CMA's presentation earlier in the Meeting. The Board requested and was provided with information and reports relevant to the consideration of the Advisory Agreements, including: (i) reports regarding the services and support provided to the Fund and its shareholders by CMA; (ii) quarterly assessments of the investment performance of the Fund from CMA; (iii) periodic commentary on the reasons for the performance; (iv) presentations by the Fund's management addressing CMA's investment philosophy, investment strategy, personnel and operations; (v) compliance and audit reports concerning the Fund and CMA; (vi) disclosure information contained in the registration statement of the Trust and the Form ADV of CMA; and (vii) the memorandum from Counsel summarizing the fiduciary duties and responsibilities of the Board in reviewing and approving the Advisory Agreements, including the material factors set forth above and the types of information included in each factor that should be considered by the Board in order to make an informed decision.

The Board also requested and received various informational materials including, without limitation: (i) documents containing information about CMA, including financial information, a description of personnel and the services provided to the Fund, information on investment advice, performance, summaries of the Fund's expenses, compliance program, current legal matters and other general information; (ii) comparative expense and performance information for other mutual funds with strategies similar to the Fund; (iii) the anticipated effect of size on the Fund's performance and expenses; and (iv) benefits to be realized by CMA from its relationship with the Fund. The Board did not identify any particular information that was most relevant to its consideration to approve the Advisory Agreements.

<u>(1) The nature, extent and quality of the services provided by CMA.</u>

In this regard, the Board considered the responsibilities CMA has under the Advisory Agreements and the services provided by CMA to the Fund including, without limitation: CMA's processes for formulating investment recommendations and assuring compliance with the Fund's investment objectives and limitations; its coordination of services for the Fund among the Fund's service providers; and its efforts to promote the Fund, grow assets and assist in the distribution of the Fund's shares. The Board considered: CMA's staffing, personnel and methods of operating; the education and experience of CMA's personnel; and CMA's compliance program, policies and procedures. After reviewing the foregoing and further information from CMA, the Board concluded that the quality, extent and nature of the services provided by CMA was satisfactory and adequate for the Fund.

<u>(2) Investment performance of the Fund and CMA.</u>

In considering the investment performance of the Fund and CMA, the Trustees compared the performance of the Fund with the performance of its benchmark index and comparable funds with similar objectives and size managed by other investment advisers. The Board noted that, after the merger of the former Capital Management Mid-Cap Fund into the Fund, CMA represented that it no longer has clients with investment objectives similar to the Fund. It was noted that, prior to the merger, a group of accounts was run in a comparable manner, but with the addition of the mid-cap and small-cap stocks to the Fund's portfolio, the divergence of the portfolios is too great to provide meaningful data.

The Board considered the consistency of CMA's management of the Fund with its investment objective and policies. The Trustees also considered that Morningstar has placed the Fund in its Large Growth category which CMA believes is the appropriate comparison and that information related to this category was provided for the Board's consideration. The Board noted that while the Fund had outperformed its category median for the 1-year period ended August 31, 2022, the Fund underperformed its category median for the 3-year, 5-year and 10-year periods ended August 31, 2022 but was within the range of the category. The Board noted that the Fund had underperformed its benchmark index for the 1-year, 3-year, 5-year and 10-year periods ended August 31, 2022. Based on the foregoing, the Board concluded that the investment performance information presented for the Fund was acceptable at this time.

**2022 Annual Report 18**

------

**Additional Information (Unaudited) - continued**

<u>(3) The costs of the services provided and profits realized by CMA from the relationship with the Fund.</u>

In considering the costs of the services provided and profits realized by CMA from the relationship with the Fund, the Board considered: CMA's staffing, personnel and methods of operating; the financial condition of CMA and the level of commitment to the Fund by CMA; the expected asset levels of the Fund; and the overall expenses of the Fund. The Board considered financial statements of CMA and discussed the financial stability and profitability of the firm. The Board considered that the management fee and net expense ratio for the Fund was above the category median for the Morningstar Large Growth Category but within the range of the category. The Board noted that the Fund's assets are significantly smaller than the majority of the funds in the Morningstar category. The Board considered that CMA does not have any separate accounts which are managed similarly to the Fund but that the advisory fees charged to the Fund are comparable to those charged to CMA's other clients. Following this analysis and upon further consideration and discussion of the foregoing, the Board concluded that the fees paid to CMA by the Fund were fair and reasonable.

<u>(4) The extent to which economies of scale would be realized as the Fund grows and whether advisory fee levels reflect these economies of scale for the benefit of the investors of the Fund.</u>

In this regard, the Board considered the Fund's fee arrangements with CMA. The Trustees noted that CMA has agreed to breakpoint fee schedules in the Advisory Agreements and to an expense limitation agreement for the Fund. The Board further noted that each of these arrangements would benefit the Fund's shareholders. Following further discussion of the Fund's expected asset levels, expectations for growth, and levels of fees, the Board determined that the Fund's fee arrangements, in light of all the facts and circumstances, were fair and reasonable and that the breakpoint schedule and expense limitation arrangements provided potential savings or protection for the benefit of the Fund's investors.

<u>(5) Possible conflicts of interest and benefits derived by CMA.</u>

In considering CMA's practices regarding conflicts of interest, the Board evaluated the potential for conflicts of interest and considered such matters as: the experience and ability of the advisory and compliance personnel assigned to the Fund; the fact that CMA does not utilize soft dollars; the basis of decisions to buy or sell securities for the Fund; and the substance and administration of CMA's code of ethics. The Board considered that the Adviser benefits, indirectly from the relationship with the Fund in that commissions are paid to its affiliate, Wellington Shields & Co. Based on the foregoing, the Board determined that CMA's standards and practices relating to the identification and mitigation of possible conflicts of interest were satisfactory.

After additional consideration of the factors delineated in the memorandum provided by Counsel and further analysis by the Board, the Board determined that the compensation payable under the Advisory Agreements with respect to the Fund was fair, reasonable and within a range of what could have been negotiated at arms-length in light of all the surrounding circumstances, and it resolved to approve the Advisory Agreements with respect to the Fund.

5. LIQUIDITY RISK MANAGEMENT PROGRAM<br> During the six month period ended November 30, 2022, the Board reviewed the Fund's liquidity risk management program, adopted pursuant to Rule 22e-4 under the Investment Company Act of 1940. The program is overseen by CMA, who has delegated certain responsibilities for managing the program to a liquidity program administrator (the "LPA"). The LPA reported that it had assessed, managed and reviewed the program for the Fund taking into consideration several factors including the liquidity of the Fund's portfolio investments and the market, trading or investment specific considerations that may reasonably affect a security's classification as a liquid investment. The LPA certified that the program was adequate, effectively implemented and needed no changes at that time.

**2022 Annual Report 19**

------

**This page was intentionally left blank.**

**2022 Annual Report 20**

------

**TRUSTEES AND OFFICERS - Unaudited**

The Trustees are responsible for the management and supervision of the Fund. The Trustees set broad policies for the Fund and choose the Fund's officers. The Trustees also approve all significant agreements between the Trust, on behalf of the Fund, and those companies that furnish services to the Fund; review performance of the Advisor and the Fund; and oversee activities of the Fund. Generally, each Trustee and officer serves an indefinite term or until certain circumstances occur such as their resignation, death, or otherwise as specified in the Trust's organizational documents. Any Trustee may be removed at a meeting of shareholders by a vote meeting the requirements of the Trust's organizational documents. The following chart shows information for each Trustee, including the Trustees who are not "interested persons" as defined in the 1940 Act ("Independent Trustees") and the Trustees who are "interested persons" as defined in the 1940 Act ("Interested Trustees"), as well as each officer of the Trust. The address of each Trustee and officer, unless otherwise indicated, is 140 Broadway, 44th Floor, New York, New York 10005.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name** | **Position** | **Length of** | **Principal** | **Number of** | **Other** |
| **<u>and Age</u>** | **with the** | **<u>Time Served</u>** | **Occupation(s)** | **Portfolios** | **Directorships** |
|  | **<u>Trust</u>** |  | **During** | **Overseen by** | **Held by** |
|  |  |  | **<u>Past 5 Years</u>** | **<u>Trustee</u>** | **<u>Trustee</u>** |
| **David V. Shields \*** | **Trustee** | **12/1994 –** | **Director (since 1982) of Capital** | **1** |  |
| **Year of Birth: 1939** |  | **04/2019;** | **Management Associates, Inc.** |  |  |
|  |  | **Since** | **(registered investment adviser to** |  |  |
|  |  | **11/2019** | **All-Cap Fund); Vice-Chairman and** |  |  |
|  |  |  | **Managing Member (since** |  |  |
|  |  |  | **December 2009) of Wellington** |  |  |
|  |  |  | **Shields & Co., LLC (broker/dealer** |  |  |
|  |  |  | **and distributor to the Fund);** |  |  |
|  |  |  | **Managing Member (since** |  |  |
|  |  |  | **December 2009) of Wellington** |  |  |
|  |  |  | **Shields Capital Management, LLC** |  |  |
|  |  |  | **(registered investment adviser).** |  |  |
| **W. Jameson McFadden** | **President,** | **Since 2016** | **President, Capital Management** | **N/A** | **N/A** |
| **Year of Birth: 1981** | **Principal** |  | **Associates, Inc. (2014-present);** |  |  |
|  | **Executive** |  | **Secretary, Wellington Shields** |  |  |
|  | **Officer,** |  | **Capital Management, LLC (2009 to** |  |  |
|  | **Principal** |  | **present); Secretary and Treasurer** |  |  |
|  | **Financial** |  | **(2010-2014) and Analyst (2006-** |  |  |
|  | **Officer and** |  | **2010), Capital Management** |  |  |
|  | **Secretary** |  | **Associates, Inc.** |  |  |
| **Stephen J. Portas** | **Chief** | **Since** | **Chief Compliance Officer (since** | **N/A** | **N/A** |
| **Year of Birth: 1969** | **Compliance** | **03/2014** | **2013) and Vice President (since** |  |  |
|  | **Officer** |  | **2011) of CMA; Chief Compliance** |  |  |
|  |  |  | **Officer (2000-2011) of Midwood** |  |  |
|  |  |  | **Securities (broker-dealer).** |  |  |
| **James D. Craft** | **Treasurer** | **Since** | **Fund Administrator, Premier Fund** | **N/A** | **N/A** |
| **Year of Birth: 1982** |  | **1/2020** | **Solutions, Inc. (2007-present);** |  |  |
|  |  |  | **Chief Technology Officer, Premier** |  |  |
|  |  |  | **Fund Solutions, Inc. (2011-pre-** |  |  |
|  |  |  | **sent).** |  |  |

---

\* Basis of Interestedness: David V. Shields is an Interested Trustee because he is an officer and principal owner of Capital Management Associates, Inc., the Fund's investment adviser, and Wellington Shields & Co., LLC, the Fund's distributor.

<u>Independent Trustees</u>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  |  |  | **Principal** | **Number of** | **Other** |
| **Name** | **Position** | **Length of** | **Occupation(s)** | **Portfolios** | **Directorships** |
| **<u>and Age</u>** | **with the** | **<u>Time Served</u>** | **During** | **Overseen by** | **Held by** |
|  | **<u>Trust</u>** |  | **<u>Past 5 Years</u>** | **<u>Trustee</u>** | **<u>Trustee</u>** |
| **Michael D. Cahill** | **Independent** | **Since** | **Head Trader, CKC Capital LLC** | **1** |  |
| **Year of Birth: 1973** | **Trustee** | **11/2019** | **(since 2015); Sales Trader,** |  |  |
|  |  |  | **Wellington Shields & Co. LLC** |  |  |
|  |  |  | **(03/2011 – 03/2015).** |  |  |
| **Paul J. Camilleri** | **Independent** | **Since** | **Arbitrator for the Financial** | **1** |  |
| **Year of Birth: 1947** | **Trustee** | **02/2007** | **Industry Regulatory Authority, Inc.** |  |  |
|  |  |  | **(since 2001).** |  |  |

---

**2022 Annual Report 21**

------

**Investment Adviser**<br> Capital Management Associates, Inc.<br> 140 Broadway<br> New York, NY 10005<br>**Dividend Paying Agent,**<br> **Shareholders' Servicing Agent,**<br> **Transfer Agent**<br> Mutual Shareholder Services, LLC<br> 8000 Town Centre Drive, Suite 400<br> Broadview Heights, OH 44147<br>**Custodian**<br> U.S. Bank, NA<br> 425 Walnut Street<br> P.O. Box 1118<br> Cincinnati, OH 45201<br>**Fund Administrator**<br> Premier Fund Solutions Inc.<br> 1939 Friendship Drive, Suite C<br> El Cajon, CA 92020<br>**Legal Counsel**<br> Practus, LLP<br> 11300 Tomahawk Creek Parkway, Suite 310<br> Leawood, KS 66211<br>**Independent Registered Public Accounting Firm**<br> BBD, LLP<br> 1835 Market Street, 3rd Floor<br> Philadelphia, PA 19103<br>**Distributor**<br> Wellington Shields & Co., LLC<br> 140 Broadway<br> New York, NY 10005<br>**Sub-Distributor**<br> Arbor Court Capital LLC<br> 8000 Town Centre Drive, Suite 400<br> Broadview Heights, OH 44147<br>

This report is provided for the general information of the shareholders of the Wellington<br> Shields All-Cap Fund. This report is not intended for distribution to prospective investors<br> in the funds, unless preceded or accompanied by an effective prospectus.

------

**Item 2. Code of Ethics.**

The registrant has adopted a code of ethics that applies to the registrant's principal executive officer and the principal financial officer. The registrant has not made any amendments to its code of ethics during the covered period. The registrant has not granted any waivers from any provisions of the code of ethics during the covered period. A copy of the registrant's Code of Ethics is filed herewith.

**Item 3. Audit Committee Financial Expert.**

The registrant's board of trustees has determined that the registrant does not have an audit committee financial expert serving on its audit committee.

At this time, the registrant believes that the collective experience provided by the members of the audit committee together offer the registrant adequate oversight for the registrant's level of financial complexity.

**Item 4. Principal Accountant Fees and Services.**

(a-d) The following table details the aggregate fees billed for each of the last two fiscal years for audit fees, audit-related fees, tax fees and other fees by the principal accountant to the registrant. The principal accountant has provided no services to the adviser or any entity controlled by, or under common control with the adviser that provides ongoing services to the registrant.

---

| | | |
|:---|:---|:---|
| | FYE 11/30/2022 | FYE 11/30/2021 |
| Audit Fees | $13750 | $13500 |
| Audit-Related Fees | $0 | $0 |
| Tax Fees | $2750 | $2500 |
| All Other Fees | $0 | $0 |

---

Nature of Tax Fees: preparation of Excise Tax Statement and 1120 RIC.

(e) (1) The audit committee approves all audit and non-audit related services and, therefore, has not adopted pre-approval policies and procedures described in paragraph (c)(7) of Rule 2-01 of Regulation S-X.

(e) (2) None of the services described in paragraph (b) through (d) of this Item were approved by the audit committee pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.

(f) All of the principal accountant's hours spent on auditing the registrant's financial statements were attributed to work performed by full-time permanent employees of the principal accountant.

(g) The following table indicates the aggregate non-audit fees billed by the registrant's principal accountant for services to the registrant , the registrant's investment adviser (not sub-adviser), and any entity controlling, controlled by, or under common control with the adviser that provides ongoing services to the registrant, for the last two years.

---

| | | |
|:---|:---|:---|
| Non-Audit Fees | FYE 11/30/2022 | FYE 11/30/2021 |
| Registrant | $2750 | $2500 |
| Registrant's Investment Adviser | $0 | $0 |

---

(h) The principal accountant provided no services to the investment adviser or any entity controlling, controlled by, or under common control with the adviser that provides ongoing services to the registrant.

**Item 5. Audit Committee of Listed Companies.** Not applicable.

------

**Item 6. Investments.**

(a) Not applicable. Schedule filed with Item 1.

(b) Not applicable.

**Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.** Not applicable.

**Item 8. Portfolio Managers of Closed End Management Investment Companies.** Not applicable.

**Item 9. Purchases of Equity Securities by Closed-End Management Investment Companies and Affiliated Purchasers.** Not applicable.

**Item 10. Submission of Matters to a Vote of Security Holders.**

The registrant has not adopted procedures by which shareholders may recommend nominees to the registrant's board of trustees.

**Item 11. Controls and Procedures.**

(a) The Registrant's president and chief financial officer concluded that the disclosure controls and procedures (as defined in Rule 30a-3(c) under the Act (17 CFR 270.30a -3(c))) as of a date within 90 days of the filing date of the report that includes the disclosure required by this paragraph, based on the evaluation of these controls and procedures required by Rule 30a-3(b) under the Act (17 CFR 270.30a -3(b)) and Rules 13a-15(b) or 15d-15(b) under the Exchange Act (17 CFR 240.13a -15(b) or 240.15d -15(b)).

(b) There were no changes in the registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the Act (17 CFR 270.30a -3(d)) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

**Item 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.**

Not applicable.

**Item 13. Exhibits.**

(a)*(1) Code of Ethics*. [Filed herewith](cmitprincode.htm).

(a)*(2) Certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.* [Filed herewith.](wellingtonex99cert.htm)

(a)*(3)* Not applicable.

(a)(4) Not applicable.

(b) *Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.* [Filed herewith.](ex99906cert.htm)

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

CAPITAL MANAGEMENT FUNDS

By: <u>/s/W. Jameson McFadden</u><br> W. Jameson McFadden<br> Principal Executive Officer and Principal Financial Officer

Date: <u>1-27-23</u>

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By: <u>/s/W. Jameson McFadden</u><br> W. Jameson McFadden<br> Principal Executive Officer and Principal Financial Officer

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Date: <u>1-27-23</u>

## Ex-99.Code

**CAPITAL MANAGEMENT INVESTMENT TRUST**

 **CODE OF ETHICS FOR PRINCIPAL EXECUTIVE AND**

 **PRINCIPAL FINANCIAL OFFICERS**

**I.** **Covered Officers/Purpose of the Code** 

This code of ethics (this "Code") for Capital Management Investment Trust (the "Trust") applies to the Trust's Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer(s) (the "Covered Officers" each of whom are set forth in Exhibit A) for the purpose of promoting:

**•** honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;

**•** full, fair, accurate, timely and understandable disclosure in reports and documents that a registrant files with, or submits to, the Securities and Exchange Commission ("SEC") and in other public communications made by the Trust;

**•** compliance with applicable laws and governmental rules and regulations;

**•** the prompt internal reporting of violations of the Code to an appropriate person or persons identified in the Code; and

**•** accountability for adherence to the Code.

**II.** **Covered Officers Should Handle Ethically Actual and Apparent Conflicts of Interest** 

 **Overview.** A "conflict of interest" occurs when a Covered Officer's private interest in any material respect interferes with the interests of, or his service to, the Trust. For example, a conflict of interest would arise if a Covered Officer, or a member of his family, receives improper personal benefits as a result of his position with the Trust.

Certain conflicts of interest arise out of the relationships between Covered Officers and the Trust and already are subject to conflict of interest provisions in the Investment Company Act of 1940 ("Investment Company Act") and the Investment Advisers Act of 1940 ("Investment Advisers Act"). For example, Covered Officers may not individually engage in certain transactions (such as the purchase or sale of securities or other property, other than shares of beneficial interest of the Trust) with the Trust because of their status as "affiliated persons" of the Trust. The Trust's and the investment adviser's compliance programs and procedures are designed to prevent, or identify and correct, violations of these provisions. This Code does not, and is not intended to, repeat or replace these programs and procedures, and such conflicts fall outside of the parameters of this Code.

Although typically not presenting an opportunity for improper personal benefit, conflicts arise from, or as a result of, the contractual relationship between the Trust and the investment adviser/administrator of which the Covered Officers are also officers or employees. As a result, this Code recognizes that the Covered Officers will, in the normal course of their duties (whether formally for the Trust or for the adviser/administrator, or for both), be involved in establishing policies and implementing decisions that may have different effects on the adviser/administrator and the Trust. The participation of the Covered Officers in such activities is inherent in the contractual relationship between the Trust and the adviser/administrator and is consistent with the performance by the Covered Officers of their duties as officers of the Trust. Thus, if performed in conformity with the provisions of the Investment Company Act and the Investment Advisers Act, such activities will be deemed to have been handled ethically. In addition, it is recognized by the Trust's Board of Trustees ("Board") that the Covered Officers may also be officers or employees of one or more investment companies covered by other codes.

Other conflicts of interest are covered by the Code, even if such conflicts of interest are not subject to provisions in the Investment Company Act and the Investment Advisers Act. The following list provides <br>

------

<br>examples of conflicts of interest under the Code, but Covered Officers should keep in mind that these examples are not exhaustive. The overarching principle is that the personal interest of a Covered Officer should not be placed improperly before the interest of the Trust.

Each Covered Officer must:

**•** not use his personal influence or personal relationships improperly to influence investment decisions or financial reporting by the Trust whereby the Covered Officer would benefit personally to the detriment of the Trust;

**•** not cause the Trust to take action, or fail to take action, for the individual personal benefit of the Covered Officer to the detriment of the Trust;

**•** not use material non-public knowledge of portfolio transactions made or contemplated for the Trust to trade personally or cause others to trade personally in contemplation of the market effect of such transactions;

**•** report at least annually any affiliations or other relationships related to conflicts of interest that the Trust's Trustees and Officers Questionnaire covers.

There are some conflict of interest situations that should always be discussed with the Audit Committee of the Trust ("Audit Committee") if such situations might have a material adverse effect on the Trust. Examples of these include:

**•** service as a director/trustee on the board of any public company;

**•** the receipt of non-nominal gifts (currently gifts in excess of $100.00);

**•** the receipt of entertainment from any company with which the Trust has current or prospective business dealings, including investments in such companies, unless such entertainment is business-related, reasonable in cost, appropriate as to time and place, and not so frequent as to raise any questions of impropriety;

**•** any ownership interest in, or any consulting or employment relationship with, any of the Trust's service providers, other than its investment adviser, principal underwriter, administrator or any affiliated person thereof;

**•** a direct or indirect financial interest in commissions, transaction charges or spreads paid by the Trust for effecting portfolio transactions or for selling or redeeming shares other than an interest arising from the Covered Officer's employment, such as compensation or equity ownership.

**III.** **Disclosure and Compliance** 

**•** each Covered Officer should familiarize himself with the disclosure requirements generally applicable to the Trust;

**•** each Covered Officer should not knowingly misrepresent, or cause others to misrepresent, facts about the Trust to others, whether within or outside the Trust, including to the Trust's trustees and auditors, and to governmental regulators and self-regulatory organizations;

**•** each Covered Officer should, to the extent appropriate within his area of responsibility, consult with other officers and employees of the Trust (including, as appropriate, the Trust's Disclosure Control Committee) and the adviser/administrator with the goal of promoting full, fair, accurate, timely and understandable disclosure in the reports and documents the Trust files with, or submits to, the SEC and in other public communications made by the Trust; and

**•** &nbsp;&nbsp;&nbsp;&nbsp; it is the responsibility of each Covered Officer to promote compliance with
 the standards and restrictions imposed by applicable laws, rules and
 regulations.

------

**IV.** **Reporting and Accountability** 

Each Covered Officer must:

**•** upon adoption of the Code (or thereafter as applicable, upon becoming a Covered Officer), affirm in writing to the Board that he has received, read, and understands the Code;

**•** annually thereafter affirm to the Board that he has complied with the requirements of the Code;

**•** not retaliate against any other Covered Officer or any employee of the Trust or their affiliated persons for reports of potential violations that are made in good faith; and notify the Chairman of the Audit Committee for the Trust promptly if he/she knows of any material violation of this Code. The Audit Committee is responsible for applying this Code to specific situations in which questions are presented under it and has the authority to interpret this Code in any particular situation. In addition, any approvals or waivers sought by a Covered Officer will be considered by the Audit Committee.

The Trust will follow the following procedures in investigating and enforcing this Code:

**•** the compliance officer of the investment adviser to the Trust, Capital Management Associates, Inc. (or such other Trust officer or other investigator as the Audit Committee may from time to time designate) (the "Investigator"), shall take appropriate action to investigate any potential violations reported to him;

**•** if, after such investigation, the Investigator believes that no violation has occurred, the Investigator is not required to take any further action;

**•** any matter that the Investigator believes is a violation will be reported to the Audit Committee;

**•** if the Audit Committee concurs that a violation has occurred, it will inform and make a recommendation to the Board, which will consider appropriate action, which may include review of, and appropriate modifications to, applicable policies and procedures; notification to appropriate personnel of the investment adviser/administrator or its board; or a recommendation to dismiss the Covered Officer;

**•** the Audit Committee will be responsible for granting waivers, as appropriate; and

**•** any changes to or waivers of this Code will, to the extent required, be disclosed as provided by SEC rules.

Any potential violation of this Code by the Investigator shall be reported to the Chairman of the Audit Committee and the Audit Committee shall appoint an alternate Trust officer or other investigator to investigate the matter.

**V.** **Other Policies and Procedures** 

This Code shall be the sole code of ethics adopted by the Trust for purposes of Section 406 of the Sarbanes-Oxley Act of 2002 and the rules and forms applicable to registered investment companies thereunder. Insofar as other policies or procedures of the Trust, the Trust's adviser, principal underwriter, or other service providers govern or purport to govern the behavior or activities of the Covered Officers who are subject to this Code, they are superseded by this Code to the extent that they overlap or conflict with the provisions of this Code. The Trust's and its investment adviser's and principal underwriter's codes of ethics under Rule 17j-1 under the Investment Company Act are separate requirements applying to the Covered Officers and others, and are not part of this Code.

**VI.** **Amendments** 

Any material amendments to this Code, other than amendments to Exhibit A, must be approved or ratified by a majority vote of the Board, including a majority of independent trustees.

------

**VII.** **Confidentiality** 

All reports and records prepared or maintained pursuant to this Code will be considered confidential and shall be maintained and protected accordingly. Except as otherwise required by law or regulation or this Code, such matters shall not be disclosed to anyone other than the Board and the Audit Committee.

**VIII.** **Internal Use** 

The Code is intended solely for the internal use by the Trust and does not constitute an admission, by or on behalf of the Trust, as to any fact, circumstance, or legal conclusion.

Date: January 19, 2016

------

 **Exhibit A**

 <u>Persons Covered by this Code of Ethics</u>

W. Jameson McFadden, President, Principal Executive Officer

and Principal Financial Officer

**Amended as of January 19, 2016**

## Ex-99.Cert

Exhibit 99.CERT

CERTIFICATIONS

I, W. Jameson McFadden, certify that:

1. I have reviewed this report on Form N-CSR of Capital Management Investment Trust;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; d)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: <u>1-27-23</u> 

 <u>/s/W. Jameson McFadden</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; W. Jameson McFadden

Principal Executive Officer and Principal Financial Officer

## Exhibit 99.906

EX-99.906CERT

 **CERTIFICATION**

I, W. Jameson McFadden, Principal Executive Officer and Principal Financial Officer of the Capital Management Investment Trust (the "Registrant"), certify to the best of my knowledge that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.

The Registrant's periodic report on Form N-CSR for the period ended November 30, 2022 (the "Form N-CSR") fully complies with the requirements of Sections 15(d) of the Securities Exchange Act of 1934, as amended; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.

The information contained in the Form N-CSR fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 <u>/s/W. Jameson McFadden</u> 

W. Jameson McFadden

President, Principal Executive Officer and

Principal Financial Officer

Date: <u>1-27-23</u> 

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to Capital Management Investment Trust and will be retained by Capital Management Investment Trust and furnished to the Securities and Exchange Commission (the "Commission") or its staff upon request.

This certification is being furnished to the Commission solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Form N-CSR filed with the Commission.

<br>